anticancer therapy (SuperGen)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanticancer therapy (SuperGen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsSkin NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInflazyme Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals IncInflazyme Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsSkin NeoplasmsColonic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A